Skip to main content

Wnt Signaling in Endocrine and Metabolic Disorders

43kviews
Editorial07 August 2023
Editorial: Wnt signaling in endocrine and metabolic disorders

The present Research Topic, entitled "Wnt Signaling in Endocrine and Metabolic Disorders" aims at emphasizing the functional role of Wnt signaling pathway in human endocrinology, with a focus on metabolic disease.Endocrine and metabolic disorders encompass a wide range of conditions affecting various organ systems and physiological processes. The Wnt signaling pathway, originally recognized for its role in embryonic development and tissue homeostasis (1,2), has emerged as a crucial player in the pathogenesis of several human disorders, including cancer (3,4), with a major contribution to disease progression and potential therapeutic implications (5)(6)(7).

Qing' E Formula" (MQEF), used for more than 1300 years in China as a treatment for lumbodynia, may exert its therapeutic effect on steroid-induced ischemic necrosis of the femoral head, is through targeting exosomal microRNAs (miRNAs) to regulate multiple signaling pathways, including Wnt, PI3K-Akt, and MAPK (8). In another original report investigating miRNAs and Wnt signaling, Alok Tripathi and collaborators demonstrate that overexpressing miR-539-3p in osteoblasts downregulates several components of the Wnt signaling and deteriorates trabecular microarchitecture leading to decreased bone formation in ovariectomized mice (9). In the third original article of our research topic, a group of investigators led by Xiaolin Tu, found that the small molecule C91 (CHIR99021) promotes osteogenic differentiation of bone marrow stromal cells via the activation of Wnt signaling (10).Paulina Vilaseca and colleagues (11) provide an interesting overview of the functional roles of estrogen deficiency in the processes involved in the development of Alzheimer's Disease, including Wnt signaling and glucose transport in the brain, amyloid precursor protein processing to form senile plaques, and Tau phosphorylation forming neurofibrillary tangles.A very comprehensive review concludes our Research Topic: Carolina Franco and collaborators elegantly explain the main differences between the physiological roles of the canonical Wnt signaling (essential for cell growth, tissue remodeling, and organ formation) and its pathological involvement in the development of a number of human diseases, including cancer (12). Correctly interpreting the molecular bases of Wnt signaling and metabolism, ideally in a cell-type and tissuespecific manner (12)(13)(14)(15), may provide a formidable knowledge for biomedical scientists and clinicians, holding the promise to produce novel therapies.In conclusion, understanding the intricate interplay between Wnt signaling and endocrine/metabolic disorders holds great promise for the development of targeted therapies and improved patient outcomes.

2,054 views

4 citations

ORIGINAL RESEARCH
29 September 2022
MiR-539-3p impairs osteogenesis by suppressing Wnt interaction with LRP-6 co-receptor and subsequent inhibition of Akap-3 signaling pathway
Alok Tripathi, 6 more and Divya Singh

3,870 views

14 citations

ORIGINAL RESEARCH
10 August 2022
The analysis of Modified Qing’ E Formula on the differential expression of exosomal miRNAs in the femoral head bone tissue of mice with steroid-induced ischemic necrosis of femoral head

3,870 views

7 citations

A Highly Selective GSK-3β Inhibitor CHIR99021 Promotes Osteogenesis by Activating Canonical and Autophagy-Mediated Wnt Signaling
ORIGINAL RESEARCH
18 July 2022
A Highly Selective GSK-3β Inhibitor CHIR99021 Promotes Osteogenesis by Activating Canonical and Autophagy-Mediated Wnt Signaling
Bo Wang, 5 more and Xiaolin Tu
The discovery and application of small molecule drugs is one of the practical strategies of safe osteogenic drugs. The small molecule CHIR99021 (C91) is a highly specific, safe, and most effective GSK-3β Inhibitor. This study found that it efficiently activates the canonical Wnt signaling of bone marrow stromal cell line ST2 and promotes osteoblast differentiation and mineralization. C91 increases the production and biochemical activity of osteoblast marker alkaline phosphatase, the expression of osteoblast marker genes Alpl, Bglap, Runx2, and Sp7, and the formation of bone nodules. Triptonide is a transcription inhibitor of Wnt target gene, which diminishes C91-induced osteoblast differentiation in a dose-dependent manner. At the same time, C91 also induces autophagy through autophagosome formation and conversion of autophagy biomarker LC-3Ⅰinto LC-3Ⅱ. Autophagy inhibitor 3MA partially reduces C91-induced osteoblast differentiation and mineralization; Autophagy inducer Rapamycin increases the expression of β-catenin to promote osteogenic differentiation, but cannot alleviate the inhibition of Triptonide on C91-induced osteogenic differentiation, indicating the crosstalk of canonical Wnt signaling and autophagy regulates C91-induced osteoblast differentiation. Furthermore, in order to simulate the in vivo detection of C91 in osteogenesis process, we established a C91 slow-release hydrogel by our newly established polycaprolactone and cell-integrated 3D printing system (PCCI3D). The sustained release C91 promotes the differentiation and mineralization of ST2 cells. C91 can also enhance the proliferative activity of ST2 cells. The release rate of C91 is 83%, and the release rate of C91 from hydrogel gradually decreases within 7 days. During this period, cell viability is maintained at 96.4%. Therefore, the small molecule Wnt agonist C91 promotes osteogenesis through autophagy and the caonical Wnt signaling pathway, which is suitable for translational application.

11,703 views

52 citations

REVIEW
6 May 2022
Metabolism and Endocrine Disorders: What Wnt Wrong?
Carolina N. Franco, 1 more and Lauren V. Albrecht

7,380 views

8 citations